⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30461478 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL26910346 | 0.98 | ALDH1A1 (0.40) | — | |
| Bromide SCHEMBL20767138 | 0.98 | ALDH1A1 (0.38) | — | |
| Hydrochloric Acid SCHEMBL657974 | 0.98 | ALDH1A1 (0.40) | — | |
| Bromide SCHEMBL20767137 | 0.96 | ALDH1A1 (0.36) | — | |
| SCHEMBL4431518 | 0.84 | PRMT5 (0.41) | — | |
| SCHEMBL507581 | 0.79 | — | — | |
| SCHEMBL30201085 | 0.79 | — | — | |
| SCHEMBL11100271 | 0.78 | HRH1 (0.49) | — | |
| SCHEMBL10041246 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4681712-A2 | PROCESS FOR THE PRODUCTION OF FERROPORTIN INHIBITORS | VIFOR (INTERNATIONAL) AG (CH) | 2026-01-21 | — | — | EP | disclosed |
| EP-4126854-B1 | PROCESS FOR THE PRODUCTION OF FERROPORTIN INHIBITORS | VIFOR INT AG (CH) | 2025-12-03 | — | — | EP | disclosed |
| EP-4615439-A2 | SOMATOSTATIN RECEPTOR SUBTYPE 4 (SSTR4) AGONISTS AND THEIR APPLICATIONS | Humanwell Pharmaceutical US, Inc. (US) | 2025-09-17 | — | — | EP | disclosed |
| EP-4499628-A1 | 2,4-DIOXOTETRAHYDROPYRIMIDINYL DERIVATIVES AS DEGRONS IN PROTACS | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2025-02-05 | — | — | EP | disclosed |
| US-20240174693-A1 | SOMATOSTATIN RECEPTOR SUBTYPE 4 (SSTR4) AGONISTS AND THEIR APPLICATIONS | YICHANG HUMANWELL PHARMACEUTICALS CO., LTD. (CN) | 2024-05-30 | — | — | US | disclosed |
| WO-2024102754-A2 | SOMATOSTATIN RECEPTOR SUBTYPE 4 (SSTR4) AGONISTS AND THEIR APPLICATIONS | HUMANWELL PHARMACUETICAL US, INC. (US) | 2024-05-16 | — | — | WO | disclosed |
| WO-2023180388-A1 | 2,4-DIOXOTETRAHYDROPYRIMIDINYL DERIVATIVES AS DEGRONS IN PROTACS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2023-09-28 | — | — | WO | disclosed |
| US-20230212159-A1 | Process for the Production of Ferroportin Inhibitors | VIFOR (INTERNATIONAL) AG (CH) | 2023-07-06 | — | — | US | disclosed |
| US-20230212159-A1 | Process for the Production of Ferroportin Inhibitors | VIFOR (INTERNATIONAL) AG (CH) | 2023-07-06 | — | — | US | disclosed |
| WO-2023107870-A1 | INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES | KINNATE BIOPHARMA INC. (US) | 2023-06-15 | — | — | WO | disclosed |
| US-11040033-B2 | Therapeutic heterocyclic compounds | GILEAD SCIENCES, INC. (US) | 2021-06-22 | — | — | US | disclosed |
| EP-3509627-A1 | LYSINE SPECIFIC HISTONE DEMETHYLASE-1 INHIBITORS AND USES THEREFOR | University of Canberra (AU) | 2019-07-17 | — | — | EP | disclosed |
| WO-2019040102-A1 | THERAPEUTIC HETEROCYCLIC COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2019-02-28 | — | — | WO | disclosed |
| WO-2018045422-A1 | LYSINE SPECIFIC HISTONE DEMETHYLASE-1 INHIBITORS AND USES THEREFOR | UNIVERSITY OF CANBERRA (AU) | 2018-03-15 | — | — | WO | disclosed |
| EP-2118101-B1 | IMIDAZO [1,5-A] PYRIDINE DERIVATIVES AS INHIBITORS OF GLUTAMINYL CYCLASE | PROBIODRUG AG (DE) | 2012-09-26 | — | — | EP | disclosed |
| US-7803810-B2 | Inhibitors | PROBIODRUG AG (DE) | 2010-09-28 | — | — | US | disclosed |
| EP-2118101-A1 | IMIDAZO [1,5-A] PYRIDINE DERIVATIVES AS INHIBITORS OF GLUTAMINYL CYCLASE | Probiodrug AG (DE) | 2009-11-18 | — | — | EP | disclosed |
| US-20080234313-A1 | NOVEL INHIBITORS | PROBIODRUG AG (DE) | 2008-09-25 | — | — | US | disclosed |
| WO-2008110523-A1 | IMIDAZO [1,5-A] PYRIDINE DERIVATIVES AS INHIBITORS OF GLUTAMINYL CYCLASE | PROBIODRUG AG (DE) | 2008-09-18 | — | — | WO | disclosed |
| CN-101239978-A | Imidazopyridines compounds | UNIV SOUTHERN MEDICAL (CN) | 2008-08-13 | — | — | CN | disclosed |